Comparing the Effect of Using Lidocaine Spray and ShotBlocker on Pain Level During Intramuscular Injection: A Clinical Trial
- Conditions
- Patients receiving intramuscular injections {diclofenac sodium} who are admitted to the emergency department.
- Registration Number
- IRCT20240127060820N1
- Lead Sponsor
- niversity of Kerbala
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Adult participants between the ages of 18 – 60 years old; did not receive analgesics/sedatives during the past 24 hours; voluntary participated in the study; patient did not have fibrosis, wound, infection and tenderness in the injection site: patients who entered the Emergency Department and were prescribed analgesics by the physicians: have no problems communicating and are fully conscious: patient not have diseases Gastric Ulcers and Asthma.
Patients who refused to participate in the study; individuals with communication difficulties or unconsciousness, those with fibrosis, wounds, or infections at the injection site, individuals involved in Road Traffic Accidents (RTA), stab wounds, or bleeding injuries. Patients receiving medication (such as antibiotics or analgesics) intravenously or intramuscularly, pregnant women, and individuals experiencing side effects of Diclofenac Sodium like gastric ulcers and asthma were also excluded from the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome variable is the level of pain during intramuscular injection that can be changed based on using shotblocker and lidocaine spray. Timepoint: immediate after intervention (intramuscular injection ) using visual analog scale and after three weeks to measurement of the primary outcome. Method of measurement: measurement pain level after intramuscular injection by using visual analog scale.
- Secondary Outcome Measures
Name Time Method